1)日本膵臓学会膵癌診療ガイドライン改訂委員会(編):膵癌診療ガイドライン2019年版.金原出版,2019,pp 166-168
2)Di Carlo V, Gianotti L, Balzano G, et al:Complications of pancreatic surgery and the role of perioperative nutrition. Dig Surg 16:320-326, 1999
3)Gianotti L, Braga M, Gentilini O, et al:Artificial nutrition after pancreaticoduodenectomy. Pancreas 21:344-351, 2000
4)Mack LA, Kaklamanos IG, Livingstone AS, et al:Gastric decompression and enteral feeding through a double-lumen gastrojejunostomy tube improves outcomes after pancreaticoduodenectomy. Ann Surg 240:845-851, 2004
5)Grizas S, Gulbinas A, Barauskas G, et al:A comparison of the effectiveness of the early enteral and natural nutrition after pancreatoduodenectomy. Medicina(Kaunas)44:678-686, 2008
6)Tien YW, Yang CY, Wu YM, et al:Enteral nutrition and biliopancreatic diversion effectively minimize impacts of gastroparesis after pancreaticoduodenectomy. J Gastrointest Surg 13:929-937, 2009
7)Park JS, Chung HK, Hwang HK, et al:Postoperative nutritional effects of early enteral feeding compared with total parental nutrition in pancreaticoduodectomy patients:a prosepective, randomized study. J Korean Med Sci 27:261-267, 2012
8)Perinel J, Mariette C, Dousset B, et al:Early enteral versus total parenteral nutrition in patients undergoing pancreaticoduodenectomy:a randomized multicenter controlled trial(Nutri-DPC). Ann Surg 264:731-737, 2016
9)Gianotti L, Besselink MG, Sandini M, et al:Nutritional support and therapy in pancreatic surgery:A position paper of the International Study Group on Pancreatic Surgery(ISGPS). Surgery 164:1035-1048, 2018
10)Tanaka M, Heckler M, Mihaljevic AL, et al:Meta-analysis of effect of routine enteral nutrition on postoperative outcomes after pancreatoduodenectomy. Br J Surg 106:1138-1146, 2019
11)Guan H, Chen S, Huang Q:Effects of enteral immunonutrition in patients undergoing pancreaticoduodenectomy:a meta-analysis of randomized controlled trials. Ann Nutr Metab 74:53-61, 2019
12)Kang YK, Dong L, Ge Y, et al:Short-term clinical outcomes of enteral nutrition versus parenteral nutrition after surgery for pancreatic cancer:a meta-analysis. Transl Cancer Res 8:1403-1411, 2019
13)Cai J, Yang G, Tao Y, et al:A meta-analysis of the effect of early enteral nutrition versus total parenteral nutrition on patients after pancreaticoduodenectomy. HPB(Oxford)22:20-25, 2020
14)American Diabetes Association:Diagnosis and classification of diabetes mellitus. Diabetes Care 35(Suppl 1):S64-S71, 2012
15)Niwano F, Hiromine Y, Noso S, et al:Insulin deficiency with and without glucagon:a comparative study between total pancreatectomy and type 1 diabetes. J Diabetes Investig 9:1084-1090, 2018
16)Wu L, Nahm CB, Jamieson NB, et al:Risk factors for development of diabetes mellitus(Type 3c)after partial pancreatectomy:a systematic review. Clin Endocrinol(Oxf)92:396-406, 2020
17)Wittingen J, Frey CF:Islet concentration in the head, body, tail and uncinate process of the pancreas. Ann Surg 179:412-414, 1974
18)Niwano F, Babaya N, Hiromine Y, et al:Glucose metabolism after pancreatectomy:opposite extremes between pancreaticoduodenectomy and distal pancreatectomy. J Clin Endocrinol Metab 106:e2203-e2214, 2021
19)Whitcomb DC, Lehman GA, Vasileva G, et al:Pancrelipase delayed-release capsules(CREON)for exocrine pancreatic insufficiency due to chronic pancreatitis or pancreatic surgery:a double-blind randomized trial. Am J Gastroenterol 105:2276-2286, 2010
20)Seiler CM, Izbicki J, Varga-Szabo L, et al:Randomised clinical trial:a 1-week, double-blind, placebo-controlled study of pancreatin 25000 Ph. Eur. minimicrospheres(Creon 25000 MMS)for pancreatic exocrine insufficiency after pancreatic surgery, with a 1-year open-label extension. Aliment Pharmacol Ther 37:691-702, 2013
21)Yamazaki S, Takayama T, Higaki T, et al:Pancrelipase with branched-chain amino acids for preventing nonalcoholic fatty liver disease after pancreaticoduodenectomy. J Gastroenterol 51:55-62, 2016
22)Satoi S, Sho M, Yanagimoto H, et al:Do pancrelipase delayed-release capsules have a protective role against nonalcoholic fatty liver disease after pancreatoduodenectomy in patients with pancreatic cancer?:a randomized controlled trial. J Hepatobiliary Pancreat Sci 23:167-173, 2016
23)Yasukawa K, Shimizu A, Yokoyama T, et al:Preventive effect of high-dose digestive enzyme management on development of nonalcoholic fatty liver disease after pancreaticoduodenectomy:a randomized controlled clinical trial. J Am Coll Surg 231:658-669, 2020
24)Roberts KJ, Schrem H, Hodson J, et al:Pancreas exocrine replacement therapy is associated with increased survival following pancreatoduodenectomy for periampullary malignancy. HPB(Oxford)19:859-867, 2017
25)松本逸平,吉田雄太,川口晃平,他:膵全摘術後栄養障害とQOL.胆と膵39:475-479,2018
26)Suto H, Kamei K, Kato H, et al:Diabetic control and nutritional status up to 1 year after total pancreatectomy:a nationwide multicentre prospective study. Br J Surg 108:e237-e238, 2021